Modeled liver-linked onset geometry for sildenafil is a PK→PD construct describing how absorption rate, absorption timing, solubility, gastric emptying, distribution loading, distribution geometry, clearance geometry, and dose-scaling geometry shape the rising-phase trajectory under liver-function-modified parameter sets. “Onset” refers strictly to modeled PK→PD behavior, not real-world timing. Absorption rate determines rising-phase steepness, absorption timing determines temporal alignment, solubility determines dissolution-driven availability, and liver-function-modified gastric emptying determines modeled input arrival. Distribution loading determines early central availability, distribution geometry determines compartmental spread, and clearance geometry determines removal dynamics. Dose-scaling geometry determines how liver-function-modified input is represented relative to a reference trajectory. PD interpretation then defines modeled onset geometry: threshold placement establishes the onset boundary, binding sensitivity transforms concentration differences, coupling geometry shapes downstream transitions, and PD noise bands add interpretation variability. These variables collectively define a mathematical liver-linked speed surface. Link to onset time.
Modeled hepatic-metabolism geometry for sildenafil represents how liver-linked clearance and metabolic processing reshape the PK trajectory within a defined model. Faster modeled hepatic clearance compresses the concentration trajectory, while slower modeled clearance extends its persistence within the modeled coordinate system. Distribution geometry determines how absorbed material spreads across modeled compartments, while redistribution timing determines the placement and magnitude of secondary concentration features. First-pass metabolism modifies the modeled systemic fraction entering subsequent compartments, and CYP3A4 metabolism geometry represents an enzyme-linked component of the modeled clearance structure. Bioavailability therefore interacts with dose-scaling geometry to determine the effective systemic input used by the model. Concentration-dependent clearance can further alter trajectory curvature as concentration changes. Tmax geometry locates the modeled peak in time, while Cmax geometry defines its vertical position. Together, these parameters generate the modeled hepatic-metabolism surface used as the PK input for subsequent PD transformation. Link to metabolism speed.
PD geometry determines how liver-linked PK differences are translated into modeled onset and hepatic-metabolism interpretation coordinates. Threshold placement determines where a modeled PK trajectory intersects the selected PD boundary. Binding sensitivity determines how concentration differences are transformed into binding differences; higher modeled sensitivity can expand separation between trajectories, while lower sensitivity can compress that separation. Coupling geometry determines how binding is mapped into a downstream PD coordinate; shallow modeled slopes broaden transitions, whereas steep slopes compress them. PD noise bands widen or narrow the region surrounding the modeled interpretation boundary without changing the underlying PK trajectory. Because liver-linked sildenafil can be represented by differing parameter sets for absorption rate, solubility, gastric emptying, distribution loading, distribution geometry, clearance geometry, bioavailability, Tmax geometry, and Cmax geometry, the PK→PD mapping can expand or compress modeled differences. The resulting geometry remains a mathematical interpretation framework rather than a real-world timing statement. Link to peak variability comparison.
Within a liver-linked PK model, absorption rate controls the slope of incoming drug mass, absorption timing positions that input along the time axis, and solubility determines the modeled dissolution contribution to available input. Gastric emptying determines when material enters the absorption compartment, while absorption-window width determines how concentrated or distributed the input becomes across time. Distribution loading sets the initial amount entering central distribution, and distribution geometry determines movement between modeled compartments. Redistribution timing can create secondary changes in the concentration trajectory. First-pass metabolism and hepatic clearance geometry then modify the fraction and rate of material represented systemically. CYP3A4 geometry supplies an enzyme-linked clearance component, while bioavailability and dose-scaling geometry determine the modeled scale of systemic exposure. Tmax geometry identifies the modeled peak coordinate, and Cmax geometry defines its magnitude. These interacting parameters form the PK trajectory subsequently transformed through the PD layer. Link to absorption rate.
PK variability can be represented as a family of trajectories rather than a single curve. Changes in absorption rate alter rising-phase steepness, while absorption timing and gastric emptying shift the position of that rising phase. Solubility and absorption-window width modify the distribution of input across time. Distribution loading and distribution geometry alter the relationship between incoming mass and central concentration, while redistribution timing can introduce different curvature patterns after the initial rise. Clearance geometry, first-pass metabolism, CYP3A4 geometry, and hepatic clearance geometry modify the descending and tail portions of each modeled trajectory. Bioavailability and dose-scaling geometry change vertical exposure scaling, while concentration-dependent clearance can make the trajectory curvature vary with concentration. Tmax and Cmax therefore emerge from the combined parameter set rather than from one isolated mechanism. The resulting family of curves defines modeled onset and metabolism windows within the mathematical coordinate system. Link to distribution speed.
| PK Domain | Liver Interaction | Link |
|---|---|---|
| Clearance Geometry | Tail-phase compression/extension. | elimination speed |
| First-Pass Metabolism | Systemic fraction shaping. | metabolism speed |
| CYP3A4 Geometry | Enzyme-linked clearance. | cyp3a4 speed |
Threshold placement determines the coordinate at which a modeled concentration trajectory is interpreted as crossing a selected PD boundary. In liver-linked parameter sets, changes in absorption, bioavailability, distribution, or clearance can move the PK trajectory relative to that fixed boundary. A trajectory with a steeper modeled rise may intersect the threshold over a narrower time coordinate, whereas a shallower trajectory can produce a broader crossing region. Binding sensitivity then determines how changes in concentration are represented in the modeled binding coordinate. Coupling geometry maps that binding coordinate into a downstream PD variable, so the same PK separation can appear differently depending on the selected coupling slope and curvature. PD noise bands represent a modeled uncertainty region around the interpretation coordinate. These elements do not alter the underlying hepatic PK equations; instead, they transform PK trajectories into a separate PD representation. The resulting liver-linked onset geometry is therefore defined by parameterized intersections. Link to pd speed.
Binding sensitivity, coupling geometry, and PD noise bands can amplify or compress differences between modeled liver-linked trajectories without changing the underlying PK input. Binding sensitivity establishes the response scale applied to concentration differences, so a given PK separation can map to a larger or smaller binding separation. Coupling geometry then determines how that binding coordinate propagates into the modeled downstream PD signal. A shallow coupling slope distributes the transition across a wider coordinate range, whereas a steep slope concentrates the transition. PD noise bands add a surrounding interpretation region that can overlap between trajectories even when their PK curves remain distinct. The PK layer supplies absorption rate, absorption timing, gastric emptying, solubility, distribution loading, distribution geometry, redistribution timing, first-pass metabolism, CYP3A4 geometry, hepatic clearance, bioavailability, dose scaling, Tmax, Cmax, and concentration-dependent clearance. The PD layer transforms those inputs into modeled interpretation geometry rather than clinical timing or outcome claims. Link to pk speed.
| PD Domain | Liver PD Interaction | Link |
|---|---|---|
| Threshold Placement | Earlier/later onset coordinate. | onset time |
| Binding Sensitivity | Amplification/compression. | onset variability comparison |
| Coupling Geometry | Slope-driven shaping. | peak variability comparison |
Modeled liver-linked onset and metabolism differences emerge from the interaction of multiple PK parameters rather than from a single liver-related variable. Absorption rate controls the slope of incoming drug mass, while absorption timing and gastric emptying position that input along the model time axis. Solubility and absorption-window width determine how the input is distributed. Distribution loading and distribution geometry shape central exposure, and redistribution timing influences later concentration features. First-pass metabolism, CYP3A4-linked metabolism geometry, hepatic clearance geometry, and concentration-dependent clearance modify the trajectory after systemic input is generated. Bioavailability and dose-scaling geometry change exposure magnitude, while Tmax and Cmax describe resulting peak coordinates. PD parameters then transform the PK trajectory through threshold placement, binding sensitivity, coupling geometry, and noise bands. Thus, liver-linked differences are represented as changes in trajectory geometry and PK→PD mapping, not as statements about actual timing or clinical effects.
The modeled PK mechanisms include absorption, distribution, metabolism, and elimination components that interact across the entire trajectory. Absorption rate determines the modeled steepness of the rising phase, while absorption timing establishes its temporal position. Gastric emptying controls modeled arrival into the absorption process, and solubility influences dissolution-driven input. Absorption-window width determines whether input is concentrated or dispersed. Distribution loading and distribution geometry determine how material enters and moves through modeled compartments, while redistribution timing can generate secondary trajectory features. First-pass metabolism modifies the modeled systemic fraction, and CYP3A4 metabolism geometry represents an enzyme-linked component of hepatic processing. Hepatic clearance geometry controls the removal structure, while concentration-dependent clearance can change curvature across concentration ranges. Bioavailability and dose-scaling geometry establish exposure scaling. Tmax and Cmax are resulting geometric descriptors of the trajectory. Together, these mechanisms define a parameterized PK surface that can be passed into a separate PD interpretation layer.
The principal PD mechanisms are threshold placement, binding sensitivity, coupling geometry, and PD noise bands. Threshold placement establishes the modeled coordinate at which a PK trajectory is translated into an onset boundary. Binding sensitivity determines how concentration differences are converted into differences on a binding-related coordinate. Coupling geometry controls how that binding coordinate is mapped into a downstream PD representation, including the slope and curvature of the transformation. PD noise bands surround the modeled interpretation with a defined variability region. These parameters operate after the PK trajectory has been generated, so they do not directly modify absorption, distribution, metabolism, or clearance equations. Instead, they determine how differences in those PK trajectories appear when represented in PD coordinates. A change in hepatic clearance geometry, for example, can shift the PK curve, while the same PD threshold and coupling functions determine how that shift is represented. The complete interpretation is therefore a mathematical PK→PD mapping.
Different parameter sets produce different trajectories because each parameter changes a distinct geometric property of the modeled system. Increasing or decreasing absorption rate changes rising-phase slope, while absorption timing and gastric emptying shift input placement. Solubility and absorption-window width alter the shape and spread of incoming material. Distribution loading changes initial central availability, while distribution geometry and redistribution timing alter compartmental movement and subsequent curvature. First-pass metabolism and CYP3A4 geometry modify modeled systemic input and metabolic processing, while hepatic clearance geometry changes the removal profile. Bioavailability and dose-scaling geometry alter exposure scale, and concentration-dependent clearance can produce concentration-dependent curvature. Tmax and Cmax consequently change as emergent coordinates of the combined parameter set. When the resulting PK curves are passed through identical or different PD functions, threshold placement, binding sensitivity, coupling geometry, and noise bands can further alter their representation. The resulting differences are model-generated geometric differences rather than assertions about real-world liver function or outcomes.
PK→PD mapping separates generation of a concentration trajectory from its interpretation in a modeled response coordinate. The PK layer combines absorption rate, absorption timing, gastric emptying, solubility, distribution loading, distribution geometry, redistribution timing, first-pass metabolism, CYP3A4 metabolism geometry, hepatic clearance, bioavailability, dose scaling, Tmax, Cmax, and concentration-dependent clearance. This produces a mathematical concentration-time trajectory. The PD layer then applies threshold placement, binding sensitivity, and coupling geometry to transform that trajectory into a modeled interpretation. PD noise bands add a defined region around the transformed signal. A change in hepatic-metabolism parameters can therefore shift, steepen, flatten, compress, or extend portions of the PK trajectory, while the PD transformation determines how those geometric changes appear in the interpreted coordinate system. The framework explains modeled liver-linked onset and metabolism differences as consequences of parameter interactions and mappings. It does not assign real-world timing, disease effects, safety implications, or patient outcomes to those modeled trajectories.